Restrictive vs. Constrictive Cardiomyopathy

Restrictive cardiomyopathy and constrictive pericarditis are two distinct conditions that produce strikingly similar symptoms, both causing the heart to fill poorly during relaxation and leading to signs of heart failure, particularly fluid buildup, swollen legs, and shortness of breath. The fundamental difference is anatomical: restrictive cardiomyopathy is a disease of the heart muscle itself, which becomes stiff from the inside, while constrictive pericarditis is a disease of the sac surrounding the heart, which tightens from the outside. Telling them apart matters enormously because constrictive pericarditis can often be cured with surgery, whereas restrictive cardiomyopathy generally requires long-term medical management or, in some cases, a heart transplant.

Where the Problem Sits

In restrictive cardiomyopathy, the heart’s walls become rigid due to changes within the muscle tissue. Abnormal proteins, scar tissue, or other deposits infiltrate or replace healthy muscle fibers, making the ventricles unable to stretch and fill properly during each heartbeat. Preclinical studies using transgenic mouse models have shown that mutations in certain heart muscle proteins can dramatically increase the muscle fibers’ sensitivity to calcium, which disrupts the normal relaxation process and eventually leads to stiffness of both contraction and relaxation over time.¹ At the cellular level, even a single gene mutation in a heart muscle protein can directly cause individual heart cells to lose their compliance, independent of calcium cycling or any change in overall heart shape.²

In constrictive pericarditis, the problem is external. The pericardium, the thin double-layered sac that cushions the heart, becomes scarred, thickened, or calcified. This rigid shell prevents the heart from expanding freely when blood tries to fill it. The heart muscle itself may be completely normal, but it cannot stretch because the outer casing will not give. One hallmark of constriction is something called ventricular interdependence: when the stiff shell limits total heart volume, one ventricle can only fill at the expense of the other. During a breath in, the right ventricle fills more and the left ventricle fills less, creating a respiratory seesaw in blood pressure and flow that is exaggerated far beyond what happens in a healthy heart.

Why They Look So Alike at the Bedside

Both conditions produce predominantly right-sided heart failure without significant loss of the heart’s pumping strength. Patients with either condition often have a normal or near-normal ejection fraction, the standard measure of how well the heart squeezes. Instead, the problem is with filling, not squeezing. Fluid backs up into the veins, liver, and legs. The overlap in symptoms is so thorough that a significant number of people initially suspected of having ordinary heart failure with preserved ejection fraction actually turn out to have one of these two conditions. Recognizing them is important because early diagnosis can lead to specific therapy that prolongs survival and improves quality of life.³

Both conditions can present with fatigue, exercise intolerance, abdominal swelling from an enlarged liver, and leg edema. Physical examination findings like elevated neck vein pressure and a rapid early diastolic filling sound on auscultation are common to both. The clinical overlap is real enough that even experienced cardiologists sometimes cannot tell them apart without dedicated testing.

What Causes Each Condition

Restrictive cardiomyopathy is the least common form of heart muscle disease and encompasses a wide range of causes. These are broadly grouped into infiltrative diseases (where abnormal substances deposit between cells), storage diseases (where substances accumulate inside cells), and endomyocardial disorders (where the inner lining of the heart thickens or scars). Cardiac amyloidosis, in which misfolded proteins accumulate in the heart’s extracellular space, is the prototypical infiltrative cause and represents the vast majority of cases. Over 95% of cardiac amyloid cases involve either light-chain amyloidosis or transthyretin amyloidosis.⁴ Other causes include sarcoidosis, iron overload from conditions like hemochromatosis, and certain genetic mutations that present during childhood or adolescence.⁵ A growing number of elderly patients with heart failure are now being recognized as having amyloid-related restrictive cardiomyopathy, a shift driven by improved diagnostic tools.

Constrictive pericarditis has its own distinct set of triggers. In a surgical series from one center, the cause was idiopathic (meaning no identifiable trigger) in about 60% of patients, with tuberculosis accounting for roughly 22%, chronic kidney disease about 9%, and prior heart surgery or malignancy making up smaller fractions.⁶ The relative frequency of these causes varies by geography: tuberculosis is the leading cause in much of the developing world, while in North America and Europe, prior cardiac surgery, radiation therapy, and idiopathic cases dominate. Viral infections can also trigger pericarditis that occasionally progresses to constriction.

Echocardiography and the Breathing Test

Standard echocardiography, the ultrasound of the heart, is usually the first imaging step when either condition is suspected. One of its most useful tricks exploits the respiratory seesaw mentioned earlier. In constrictive pericarditis, the rigid pericardium transmits pressure changes from breathing directly into the heart chambers, producing large swings in blood flow across the heart valves with each breath. A variation of 25% or more in the peak speed of blood flowing across the mitral valve during breathing is considered characteristic of constriction.⁷ In restrictive cardiomyopathy, these respiratory swings are typically much smaller because the stiff muscle, rather than a stiff shell, is limiting filling more uniformly regardless of breathing.

This breathing-based test has a few caveats. Some patients with genuine constrictive pericarditis do not show the expected respiratory variation because their filling pressures are so high that they mask the effect. In those cases, reducing the volume of blood returning to the heart, by tilting the patient upright or giving a diuretic, can unmask the characteristic respiratory swing. In one series of surgically confirmed constriction patients who initially lacked the typical Doppler pattern, respiratory variation jumped from about 5% to about 32% after these maneuvers.⁸ Additionally, severe lung disease can produce respiratory variation that mimics constriction. One study found that patients with chronic obstructive pulmonary disease had respiratory variation in mitral valve flow that was similar to those with constrictive pericarditis (about 46% versus 41%), which means this test alone is not definitive if a patient also has significant lung disease.⁹

Another echocardiographic clue involves tissue Doppler, which measures the speed of the heart muscle itself rather than the blood flowing through it. In a healthy heart, the lateral (outer) side of the mitral valve ring moves faster than the medial (inner) side during early filling. In constrictive pericarditis, that relationship flips: the medial side moves as fast or faster than the lateral side, a pattern sometimes called “annulus reversus.” One study showed that in normal people, lateral early diastolic velocity was about 25% higher than medial, whereas in constrictive pericarditis, lateral velocity was actually 2% lower than medial.¹⁰ In restrictive cardiomyopathy, both velocities are reduced but the normal lateral-greater-than-medial pattern is preserved, making this sign a practical way to separate the two.

Cardiac MRI and Pericardial Thickness

Cardiac MRI adds information that echocardiography cannot easily provide, particularly about pericardial thickness and tissue characteristics. A thickened pericardium, generally considered anything over about 4 mm, supports a diagnosis of constrictive pericarditis, though a normal-thickness pericardium does not completely rule it out. One MRI study found that maximal pericardial thickness was significantly larger in constrictive pericarditis patients compared to those with restrictive cardiomyopathy or normal hearts.¹¹

MRI also offers a technique called late gadolinium enhancement, where a contrast dye highlights areas of scar or abnormal tissue. In the same study, about a third of restrictive cardiomyopathy patients showed late gadolinium enhancement within the heart muscle, indicating fibrosis or infiltration, while none of the constrictive pericarditis patients or normal subjects showed this finding.¹² This combination of pericardial thickness measurement and enhancement pattern within the heart muscle gives MRI genuine added value over echocardiography for the toughest cases.

A Simple Blood Test That Helps

One surprisingly helpful tool in this diagnostic puzzle is a blood test for natriuretic peptides, the hormones released by stretched heart muscle. Because constriction restricts the heart from the outside while the muscle itself is normal, the muscle is not stretched the same way, so natriuretic peptide levels tend to stay relatively low. In restrictive cardiomyopathy, the diseased muscle is under direct stress, and these peptide levels climb substantially. One study found that plasma BNP levels were dramatically higher in restrictive cardiomyopathy than in constrictive pericarditis (roughly 826 versus 128 pg/mL), despite both groups having similar elevations in pressures inside the heart.¹³ Another study using a related peptide called NT-pro-BNP found that a cutoff of 459 pg/mL could distinguish the two conditions with about 88% overall accuracy.¹⁴ No blood test is perfect, but natriuretic peptide levels provide a cheap, fast data point that can tip the balance when imaging is ambiguous.

Cardiac Catheterization for Definitive Answers

When noninvasive tests leave doubt, cardiac catheterization, threading pressure-sensing catheters directly into the heart chambers, remains the gold standard for differentiating the two conditions.¹⁵ Both conditions produce elevated filling pressures and a rapid-filling, plateau-shaped pattern sometimes called the “square root sign” or “dip-and-plateau.” The key distinction, once again, is ventricular interdependence. During breathing, the pressures in the right and left ventricles move in opposite directions in constriction: when one goes up, the other goes down. In restrictive cardiomyopathy, pressures in both ventricles tend to rise and fall together. This discordance between the two ventricles during breathing was shown to accurately distinguish constrictive pericarditis from restrictive cardiomyopathy when other hemodynamic signs overlapped.¹⁶

How Treatment Differs

This is where getting the diagnosis right pays off most clearly. Constrictive pericarditis can be treated surgically by stripping away the scarred, thickened pericardium, a procedure called pericardiectomy. The results can be dramatic. In one large Chinese series, about 80% of patients improved by at least one functional class after surgery, with five-year survival around 84%.¹⁷ A separate long-term study reported similar figures: 80% of patients showed functional improvement, and survival at one, five, and ten years was about 91%, 85%, and 81%.¹⁸ Pericardiectomy is not trivial surgery — the thirty-day mortality in the Chinese series was about 6% — but it offers a genuine shot at cure in a condition that otherwise progresses relentlessly.

Restrictive cardiomyopathy has no single surgical fix. Treatment depends heavily on the underlying cause. If amyloidosis is the culprit, disease-specific therapies aimed at stopping or clearing the abnormal protein deposits are now available and are changing outcomes for some patients. Iron overload from hemochromatosis can be addressed with iron chelation therapy. Other rare causes have their own targeted treatments.¹⁹ When no reversible cause is found, management is largely supportive: diuretics to reduce fluid overload, careful management of heart rhythm problems, and ultimately heart transplantation for patients who continue to deteriorate. The prognosis is generally worse than for constrictive pericarditis, which is precisely why distinguishing between the two is so consequential.

Transient Constriction and the Medical Alternative

Not all constrictive pericarditis requires surgery. A subset of patients have what is called transient constrictive pericarditis, where the pericardial thickening and stiffness are caused by active inflammation rather than permanent scarring. In these patients, anti-inflammatory treatment can resolve the constriction entirely, sparing them an operation. One study followed 22 patients with this pattern and found that the constrictive features resolved in an average of about eight weeks with medical therapy alone.²⁰ The concept has shifted the thinking around constriction: rather than being an exclusively surgical disease, it now sits on a spectrum from reversible inflammation to irreversible fibrosis.

Identifying transient constriction matters because operating on an inflamed but not yet scarred pericardium is unnecessary and carries real surgical risk. Cardiac MRI can help by detecting pericardial edema and inflammation, signs that the process may still be reversible. In one case report, a patient treated with a combination of colchicine, prednisone, and aspirin showed improvement from severe symptoms to mild symptoms within a week, and repeat MRI at four months confirmed decreased pericardial thickness and resolution of inflammation.²¹ Serial echocardiography is used to monitor whether the constrictive pattern is resolving, and surgery is reserved for those who do not improve.²²

When Standard Testing Leaves Doubt

Despite all the tools described above, some cases remain genuinely ambiguous. Patients with both pericardial and myocardial disease (for example, a person who had radiation therapy years ago, which can damage both the pericardium and the heart muscle) may show features of both conditions simultaneously. In those scenarios, no single test cleanly separates the two because both processes are happening at once. Cardiac catheterization may show a mix of concordant and discordant pressure patterns, echocardiography may show partial respiratory variation, and imaging may show both pericardial thickening and myocardial enhancement. These “mixed” cases often require a clinical judgment call weighing all the evidence together, and sometimes exploratory surgery is needed to settle the question definitively.

Children present another diagnostic challenge. Both conditions are uncommon in childhood, and children are less able to articulate subtle symptoms like exercise intolerance or fatigue.²³ The same diagnostic principles apply, but the underlying causes skew differently. Genetic forms of restrictive cardiomyopathy tend to appear earlier in life, while constrictive pericarditis in children is more often related to prior surgery or infection than to the idiopathic or post-radiation causes seen in adults. The stakes of misdiagnosis are arguably even higher in young patients, for whom a missed surgical cure means years of unnecessary decline.

Machine Learning and Future Diagnostics

The difficulty of this diagnostic distinction has drawn interest from researchers working on artificial intelligence tools. A deep-learning model trained on echocardiographic images was able to distinguish constrictive pericarditis from cardiac amyloidosis (the most common cause of restrictive cardiomyopathy) with an area under the curve of 0.97, which represents very high discriminatory accuracy. The model focused heavily on the ventricular septal area, consistent with the known importance of septal motion patterns in distinguishing the two conditions.²⁴ An earlier machine-learning approach combined speckle-tracking echocardiography, which tracks tiny movements of the heart muscle, with standard echo measurements and achieved an area under the curve of about 96% for telling the two apart.²⁵

These tools are still in the pilot stage and have been tested on relatively small datasets, so they are not ready to replace clinical judgment. But they point toward a future where an echo technician could upload images and receive an algorithmic second opinion in minutes, potentially catching cases that might otherwise be referred for invasive catheterization. For a diagnostic problem that has frustrated cardiologists for decades, even incremental improvements in noninvasive accuracy would be genuinely useful.

After Pericardiectomy

For patients who do undergo surgery for constrictive pericarditis, recovery is not always instant. Doppler echocardiography has been used to track respiratory variation after pericardiectomy, and the results suggest that resolution of the constrictive pattern predicts long-term outcome. In one study, respiratory variation in mitral valve flow dropped from about 17% before surgery to about 8% afterward, and variation in pulmonary vein flow dropped from about 25% to about 7%. Patients who became asymptomatic after surgery had significantly lower residual respiratory variation than those who remained symptomatic.²⁶ Incomplete removal of the pericardium, described as partial pericardiectomy, was identified in one series as a strong predictor of worse five-year survival, reinforcing the importance of thorough surgical stripping when the decision to operate has been made.²⁷ For patients and families navigating this process, understanding that incomplete symptom relief after surgery does not necessarily mean the diagnosis was wrong, but may instead reflect incomplete pericardial removal or coexisting myocardial disease, can help set realistic expectations.